EDGAR Filing Documents for 0001113423-13-000012

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001113423-13-000012

Filing Date

2013-03-22

Accepted

2013-03-21 18:49:52

Documents

Period of Report

2012-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	20-F	aezs20-f2012.htm	20-F	3754289
2	EXHIBIT	exhibit13.htm	EX-1.3	42454
3	EXHIBIT	exhibit41.htm	EX-4.1	67008
4	EXHIBIT	exhibit81.htm	EX-8.1	19988
5	EXHIBIT	exhibit121.htm	EX-12.1	12242
6	EXHIBIT	exhibit122.htm	EX-12.2	12473
7	EXHIBIT	exhibit131.htm	EX-13.1	8253
8	EXHIBIT	exhibit132.htm	EX-13.2	7672
9	EXHIBIT	exhibit151.htm	EX-15.1	4598
10		aezs108.jpg	GRAPHIC	79205
11		aezs120.jpg	GRAPHIC	67308
12		consentindependentauditoraet.jpg	GRAPHIC	21731
13		signatureernst.jpg	GRAPHIC	4345
14		signaturelimoges.jpg	GRAPHIC	4981
15		signaturepwc.jpg	GRAPHIC	7895
	Complete submission text file	0001113423-13-000012.txt		4186400

Mailing Address 1405 BOUL DU PARC TECHNOLOGIQUE QUEBEC QUEBEC A8 GIP 4P5

Business Address 1405 BOUL DU PARC TECHNOLOGIQUE QUEBEC QUEBEC A8 GIP 4P5 418 652 8525

Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-30752 | Film No.: 13708757
SIC: 2834 Pharmaceutical Preparations